
National Association of Testing Authorities, Australia
Scope of Accreditation
Silliker Australia Pty Ltd t/a Merieux NutriSciences
Site
Sydney Microbiology Laboratory
Accreditation No.
2020
Site No.
2759
Date of Accreditation
16 Nov 1989
Address
Unit C2, Regents Park Estate, 391 Park Road
Regents Park, NSW 2143
Australia
Contact
Availability
Services available to external clients
Scope of Accreditation
ISO/IEC 17025 (2017)
Healthcare, Pharmaceutical and Media Products
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Analysis for physical and chemical characteristics of cosmetics, perfumes and essentials oils | Cosmetic products; Essential oils; Perfumes | Bioburden | Filtration | ANSI/AMMI/ISO 11737-1; BS EN 1174.1 (in-house method M38) |
Analysis for physical and chemical characteristics of human and veterinary medicines including vaccines | Biological products; Pharmaceuticals | Bioburden | Filtration | BS EN 1174.1, ANSI/AMMI/ISO 11737-1 (in-house method M38) |
Biological analysis of cosmetics, perfumes and essentials oils | Cosmetic products; Essential oils; Perfumes | Preservative efficacy | Pour plate | BP Appendix XVIC (in-house method M28) USP Chapter <61> (in-house method M29) |
Clostridium perfringens; Clostridium spp.; Enterobacteriaceae; Escherichia coli; Pseudomonas aeruginosa; Pseudomonas spp.; Salmonella spp.; Staphylococcus aureus; Aerobes; Coliforms; Spores; Yeasts and moulds | Pour plate; Spread plate - Aerobic and anaerobic | FDA-BAM Chapter 23 (in-house methods M22, M24) | ||
Indicator organisms; Spores | Pour plate; Spread plate - Aerobic and anaerobic | USP Chapter <55> (in-house method M25, M39) | ||
Biological analysis of human and veterinary medicines including vaccines | Antibiotics | Bioassay | Large plate diffusion assay | in-house methods M87, M89, M90, M92, M93, M95, M96, M97, M98 |
Biological products; Pharmaceuticals | Preservative efficacy | Pour plate | BP Appendix XVIC (in-house method M28) USP Chapter <61> (in-house method M29) | |
Lactobacillus acidophilus; Lactobacillus spp. | Pour plate; Spread plate | in-house method M56 | ||
Clostridium perfringens; Clostridium spp.; Enterobacteriaceae; Escherichia coli; Lactobacillus acidophilus; Lactobacillus spp.; Pseudomonas aeruginosa; Pseudomonas spp.; Salmonella spp.; Staphylococcus aureus; Aerobes; Bacterial spores; Coliforms; Yeasts and moulds | Membrane filter; Pour plate; Spread plate | FDA-BAM Chapter 23 (in-house methods M21, M22, M24, M65) | ||
Biological analysis of medical devices | Medical devices | Clostridium perfringens; Clostridium spp.; Enterobacteriaceae; Escherichia coli; Pseudomonas aeruginosa; Pseudomonas spp.; Salmonella spp.; Staphylococcus aureus; Aerobes; Coliforms; Spores; Yeasts and moulds | Pour plate | in-house methods M21, M22, M24 |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2020
Site No.
2759
Print date
22 Oct 2025